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plicated by bilateral hearing loss with 
vestibular dysfunction. Preexisting 
medical conditions, such as alcohol-
ism, liver cirrhosis, or splenectomy, 
have been described to predispose pa-
tients to severe infection and hearing 
loss (2). Our patient, however, did not 
have any predisposing conditions.
Meningitis in humans caused by 
S. suis serotype 14 is less common 
than that caused by serotype 2, but 
the consequences are similar and can 
be reduced by early treatment with 
antimicrobial drugs. Identifying this 
case of meningitis caused by S. suis 
serotype 14 in Canada raises concerns 
about the public health aspect of this 
infection. Guidelines may be required 
to ensure that staff working in hog 
plants are aware of the risk for this 
infection and that they use adequate 
personal protective equipment. 
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Outbreaks Caused 
by New Variants of 
Vibrio cholerae O1 
El Tor, India 
To the Editor: Vibrio cholerae 
O1, the causative agent of cholera, 
has 2 biotypes (classical and El Tor), 
which have traditionally been distin-
guished by phenotypic tests and by 
genetic differences in the major toxin-
coregulated pilus (TCP) gene, the tcpA 
allele of the TCP cluster (1), the rstR 
region (regulatory region for phage ly-
sogeny) of CTX phages (2), the type 
of cholera toxin (CT) produced, and 
the infection pattern of the disease 
they cause. However, 3 variants of the 
El Tor biotype have been described re-
cently: Matlab (a place in Bangladesh) 
variants in 2002 (3), which could not 
be biotyped because they have a mix-
ture of both classical and El Tor (4), 
Mozambique variant in 2004–2005, 
which has a typical El Tor genome but 
a tandem repeat of the classical CTX 
prophage in the small chromosome 
(5), and the altered El Tor type (a typi-
cal El Tor biotype and an El Tor CTX 
prophage that produces CT of the clas-
sical type) predominant in Bangladesh 
since 2001 (6). Hybrid vibrios have 
also been described in other regions of 
Asia and Africa (7).
CT, encoded by the ctxA and ctxB 
genes, is the principal toxin produced 
by V. cholerae O1 and O139. Methods 
for differentiating the biotype-specifi c 
CT-B subunit of V. cholerae O1 in-
clude sequencing the ctxB gene, per-
forming an ELISA wth a monoclonal 
antibody specifi c to the classical or El 
Tor CT, or by using a mismatch am-
plifi cation mutation assay (MAMA)–
PCR to distinguish between 2 kinds 
of ctxB genes. This assay detects se-
quence polymorphisms based on nt 
position 203 of the ctxB gene (8).
In Punjab and Haryana states of 
northern India, during July–Septem-
ber 2007, 6 clusters of cholera out-
break were identifi ed. A total of 745 
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case-patients were admitted to local 
government hospitals; the cholera at-
tack rate was 183/1,000 population. 
Four deaths were reported (case-fa-
tality rate 0.5%). The number of cas-
es per cluster varied from 15 to 400, 
and adults were primarily affected 
(74%); 20% of patients had severe 
dehydration. V. cholerae O1 Ogawa 
was confi rmed from stool cultures by 
using standard isolation, biochemi-
cal, and serotyping methods. Twenty-
six isolates were phenotypically and 
genotypically characterized accord-
ing to biotype. Phenotypic character-
ization included the Voges-Proskauer 
reaction, polymyxin B (50 U) sus-
ceptibility, chick cell agglutination, 
and sheep erythrocyte hemolysis; all 
isolates were confi rmed as El Tor bi-
otype. Genotypic characterization in-
cluded PCR assays for ctxA and tcpA 
(2), rstR (3), and ctxB (8). All strains 
were toxigenic because each carried 
the ctxA gene. All strains also carried 
El Tor–specifi c tcpA (472 bp) and 
rstR genes (500 bp). MAMA-PCR 
showed the ctxB gene of both El Tor 
and the classical type in 21 (80%) of 
26 isolates tested.
Similarly, we also tested 20 avail-
able isolates from the 2002 outbreak 
and 4 and 19 sporadic isolates from 
2003 and 2004, respectively; all were 
phenotypically and genotypically con-
fi rmed as El Tor and had only ctxB of 
the El Tor type. Of 53 water samples 
tested during the 2007 outbreak, 4 
grew V. cholerae. Three samples were 
confi rmed to be non-O1, non-O139 
strains. Only 1 isolate was V. cholerae 
O1, which was positive for tcp, ctxA, 
and ctxB of both classical and El Tor 
types (Table).
During the cholera outbreak 
of 2002 in Chandigarh (9), only 1 
death was reported (case-fatality rate, 
<0.01%); the attack rate was 20/1,000, 
58.6% were children, and only 10% 
had severe dehydration. Before the 
most recent outbreak, the affected re-
gions of Panjab and Haryana (Amba-
la, Nurpur, Kurali, Mohali, Panchkula, 
and Raili) had been free of cholera 
outbreaks since 1994, though sporadic 
cases had been reported. The 4 deaths 
from cholera in 2007, along with adult 
preponderance, high attack rate, more 
severe illness, and 6 different clusters, 
point towards a change in the dis-
ease’s epidemiology. This change may 
be related to circulation of the hybrid 
vibrios in this region. In Bangladesh, 
all strains of V. cholerae O1 examined 
since 2001 belong to the altered El Tor 
type (6), which produces CT of the 
classical type. This altered type has 
replaced the seventh pandemic strain 
of the El Tor biotype that produced 
CT of the El Tor type, which indicates 
that a cryptic change has occurred in 
the seventh pandemic El Tor biotype 
strains of V. cholerae O1.
Newly emerged variants from 
Bangladesh (8) have the genetic 
makeup of El Tor with ctxB gene of 
only classical, whereas our strains are 
unique in having ctxB of both the clas-
sical and El Tor biotypes. Our strains 
appear to be different from the Mo-
zambique variant V. cholerae O1 (10), 
which has rstR of the classical type, in 
that our strains have rstR of only the 
El Tor type. Of 5 Matlab variants ana-
lyzed with MAMA-PCR, 3 had clas-
sical ctxB and 2 had El Tor type. Our 
study highlights the different genetic 
recombinations possible in V. cholerae 
and the epidemiologic role of these re-
combinations.  
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Table. Phenotypic and genotypic traits of Vibrio cholerae O1 clinical strains isolated from northern India, 2002–2007* 
Phenotypic tests PCR amplicons
Year of isolation or type 
of strain VP
Polymyxin B (50 U) 
susceptibility CCA
Sheep erythrocyte 
hemolysis tcpA ctxB (MAMA-PCR) rstR
2002 (n = 20) + Resistant + + E E E
2003 (n = 4) + Resistant + + E E E
2004 (n = 19) + Resistant + + E E E
2007 (n = 26) + Resistant + + E E + C (n = 21)† E
Environmental (n = 1) + Resistant + + E E + C E
Classical 569B – Sensitive – – C C C
El Tor N16961 + Resistant + + E E E
Hybrid NICED, India + Resistant + + E C E + C 
*VP, Voges-Proskauer; CCA, chick cell agglutination; MAMA, mismatch amplification mutation assay; +, positive; –, negative; E, El Tor type; C, classical 
type; NICED,  National Institute of Cholera and Enteric Diseases, Kolkata, India.                         
†Remainder had ctxB of El Tor type. 
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Human Case of 
Atopobium rimae 
Bacteremia
To the Editor: The genus Atopo-
bium (1) accommodates species 
formerly designated Lactobacillus 
minutus, L. rimae, and Streptococ-
cus parvulus (2). Use of 16S rDNA 
sequence analysis showed these spe-
cies to be closely related and to form 
a distinct line of descent within the 
lactic acid bacteria (3). Atopobium 
spp. usually have been recognized as 
part of the human gingival oral fl ora; 
some species, including A. rimae and 
A. parvulum, have been identifi ed as 
agents of chronic periodontitis (4,5). 
A. rimae, formerly known as L. rimae 
(1), forms short, gram-positive, strictly 
anaerobic, elliptical bacteria with low 
G+C content (4). A. rimae produces 
large amounts of lactic acid and has 
been recovered previously from nor-
mal human gingival fl ora (4,5). Apart 
from periodontitis, it has not been im-
plicated in other types of infection. 
We report an unusual case of A. rimae 
bacteremia.
In May 2007, a 77-year-old wom-
an with a history of right thoracotomy 
for pneumothorax 2 years earlier was 
hospitalized for inhalation pneumonia 
caused by paralysis of the right vocal 
cord. During hospitalization, septic 
shock and a fever of 38°C developed 
in the patient, complicated by acute 
respiratory failure and stroke. She was 
transferred to an intensive care unit 
with a PaO2/FiO2 >300 mm Hg, and 
a tracheotomy was performed. Three 
anaerobic blood specimens, drawn at 
entrance into the intensive care unit, 
yielded gram-positive cocci after 24-h 
incubation of the fi rst bottle and gram-
positive bacilli after 48-h incubation 
of the 2 other bottles. The gram-pos-
itive cocci were identifi ed as Strep-
tococcus gordonii using API STREP 
(bioMérieux, Marcy l’Etoile, France). 
The gram-positive bacilli were cata-
lase negative and oxidase positive 
but remained unidentifi ed with use of 
API ANA strip (bioMérieux). Mini-
mum inhibitory concentrations of 
antibiotics were determined for the 
gram-positive bacilli using E-test as-
say (AB BIODISK, Solna, Sweden) 
on Columbia agar supplemented with 
5% sheep blood. Minimum inhibitory 
concentrations were 0.064 μg/mL for 
penicillin G, 0.023 μg/mL for ampicil-
lin, 0.012 μg/mL for amoxicillin–cla-
vulanic acid, 0.032 μg/mL for imipen-
em, <0.016 μg/mL for azithromycin, 
<0.016 μg/mL for erythromycin, 0.06 
μg/mL for ciprofl oxacin, and 1.25 
μg/mL for vancomycin. DNA was 
extracted from 1 colony by using a 
QIAamp tissue kit (QIAGEN, Hilden, 
Germany) as described by the manu-
facturer. The 1,454-bp 16S rDNA 
sequence obtained using the fD1 5′-
AGAGTTTGATCCTGGCTCAG-3′ 
and rP2 5′-ACGGCTACCTTGTTAC
GACTT-3′ primer pair (6,7) showed 
99% sequence similarity with the 16S 
rDNA sequence of A. rimae (GenBank 
accession no. AF292371) by use of 
BLAST version 2.2.9 software (Na-
tional Center for Biotechnology Infor-
mation). A phylogenetic neighbor-join-
ing tree based on the Atopobium spp.
16S rDNA sequences made with the 
MEGA software confi rmed that the 
isolate belonged to A. rimae (Figure). 
Initial treatment by intravenous tazo-
cilline-amikacin was changed to in-
travenous amoxicillin–clavulanic acid 
(2 g/200 mg). The fever resolved, and 
the patient’s condition improved. The 
treatment was stopped after 7 days, 
and the patient remained apyretic.
In this case, phenotypic identifi ca-
tion of gram-positive bacillus isolated 
from 2 blood cultures failed because 
the defi nite bacterial species A. rimae 
was not included in the API database 
used for the phenotypic identifi ca-
tion. Final identifi cation was achieved 
within 2 days by comparison of the 
almost complete 16S rDNA sequence 
with homologous sequences deposited 
in Genbank. This comparison yielded 
a 99% sequence similarity, regarded 
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